Exploring the "Other" subfamily of HECT E3-ligases for therapeutic intervention

被引:27
|
作者
Singh, Sunil [1 ]
Ng, Joel [1 ]
Sivaraman, J. [1 ]
机构
[1] Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore
关键词
Other" subfamily HECT; Ubiquitination; Protein Degradation; Cancer; modification; E3 ubiquitin ligase; E3 UBIQUITIN LIGASE; GOLGI MEMBRANE DYNAMICS; INTERACTING PROTEIN 12; ANGELMAN-SYNDROME; TUMOR-SUPPRESSOR; PROTEASOMAL DEGRADATION; INTELLECTUAL DISABILITY; STRUCTURAL BASIS; HEPATOCELLULAR-CARCINOMA; POLYUBIQUITIN CHAINS;
D O I
10.1016/j.pharmthera.2021.107809
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The HECT E3 ligase family regulates key cellular signaling pathways, with its 28 members divided into three sub-families: NEDD4 subfamily (9 members), HERC subfamily (6 members) and "Other" subfamily (13 members). Here, we focus on the less-explored "Other" subfamily and discuss the recent findings pertaining to their biolog-ical roles. The N-terminal regions preceding the conserved HECT domains are significantly diverse in length and sequence composition, and are mostly unstructured, except for short regions that incorporate known substrate-binding domains. In some of the better-characterized "Other" members (e.g., HUWE1, AREL1 and UBE3C), structure analysis shows that the extended region (similar to aa 50) adjacent to the HECT domain affects the sta-bility and activity of the protein. The enzymatic activity is also influenced by interactions with different adaptor proteins and inter/intramolecular interactions. Primarily, the "Other" subfamily members assemble atypical ubiquitin linkages, with some cooperating with E3 ligases from the other subfamilies to form branched ubiquitin chains on substrates. Viruses and pathogenic bacteria target and hijack the activities of "Other" subfamily mem-bers to evade host immune responses and cause diseases. As such, these HECT E3 ligases have emerged as poten-tial candidates for therapeutic drug development. (C) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页数:22
相关论文
共 48 条
  • [1] RBR E3-ligases at work
    Smit, Judith J.
    Sixma, Titia K.
    EMBO REPORTS, 2014, 15 (02) : 142 - 154
  • [2] Regulating the human HECT E3 ligases
    Sluimer, Jasper
    Distel, Ben
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2018, 75 (17) : 3121 - 3141
  • [3] The 'Other' subfamily of HECT E3 ubiquitin ligases evaluate the tumour immune microenvironment and prognosis in patients with hepatocellular carcinoma
    Dong, Runyu
    Wang, Zhixiong
    Cao, Danping
    Li, Yanna
    Fei, Yao
    Gao, Peng
    Zhu, Menglin
    Chen, Zhiqiang
    Cai, Juan
    Zuo, Xueliang
    IET SYSTEMS BIOLOGY, 2024, 18 (01) : 23 - 39
  • [4] The Roles of NEDD4 Subfamily of HECT E3 Ubiquitin Ligases in Neurodevelopment and Neurodegeneration
    Haouari, Shanez
    Vourc'h, Patrick
    Jeanne, Mederic
    Marouillat, Sylviane
    Veyrat-Durebex, Charlotte
    Lanznaster, Debora
    Laumonnier, Frederic
    Corcia, Philippe
    Blasco, Helene
    Andres, Christian R.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (07)
  • [5] Regulating the human HECT E3 ligases
    Jasper Sluimer
    Ben Distel
    Cellular and Molecular Life Sciences, 2018, 75 : 3121 - 3141
  • [6] The Role of HECT E3 Ubiquitin Ligases in Colorectal Cancer
    Sun, Aiqin
    Chen, Yifei
    Tian, Xianyan
    Lin, Qiong
    BIOMEDICINES, 2023, 11 (02)
  • [7] Proteasomal Degradation of Zn-Dependent Hdacs: The E3-Ligases Implicated and the Designed Protacs That Enable Degradation
    Marquez-Cantudo, Laura
    Ramos, Ana
    Coderch, Claire
    de Pascual-Teresa, Beatriz
    MOLECULES, 2021, 26 (18):
  • [8] Emerging roles of the HECT E3 ubiquitin ligases in gastric cancer
    Sun, Aiqin
    Tian, Xianyan
    Chen, Yifei
    Yang, Wannian
    Lin, Qiong
    PATHOLOGY & ONCOLOGY RESEARCH, 2023, 29
  • [9] HECT E3 Ligases: A Tale With Multiple Facets
    Weber, Janine
    Polo, Simona
    Maspero, Elena
    FRONTIERS IN PHYSIOLOGY, 2019, 10
  • [10] The HECT family of E3 ubiquitin ligases and PTEN
    Song, Min Sup
    Pandolfi, Pier Paolo
    SEMINARS IN CANCER BIOLOGY, 2022, 85 : 43 - 51